Table 1 Demographic and clinical characteristics of patients pre- and post-ERAS implementation
Pre-ERAS (n = 776) | Post-ERAS (n = 1473) | P value | |||
|---|---|---|---|---|---|
n | % | n | % | ||
Age | |||||
18–24 | 37 | 4.77% | 75 | 5.09% | 0.04 |
25–34 | 359 | 46.26% | 603 | 40.94% | |
35–44 | 366 | 47.16% | 749 | 50.85% | |
>44 | 14 | 1.80% | 46 | 3.12% | |
Race | |||||
White | 347 | 44.72% | 677 | 45.96% | 0.38 |
Asian | 180 | 23.20% | 334 | 22.74% | |
Black or African American | 49 | 6.31% | 87 | 5.91% | |
Native Hawaiian or Other Pacific Islander | 16 | 2.06% | 19 | 1.29% | |
American Indian or Alaska Native | 4 | 0.52% | 8 | 0.54% | |
Unknown | 180 | 23.20% | 348 | 23.56% | |
Comorbidities | |||||
Anxiety | 3 | 0.39% | 4 | 0.27% | 0.64 |
Depression | 50 | 6.44% | 111 | 7.54% | 0.33 |
Substance use disorder | 5 | 0.64% | 13 | 0.88% | 0.54 |
Opioid-free 24 h pre-discharge | 163 | 21.01% | 733 | 49.76% | <0.01 |
Discharged with opioid prescription | 740 | 95.36% | 1189 | 80.72% | <0.01 |
Daily oral morphine equivalents on discharge prescription | |||||
>0–49 | 591 | 79.86% | 338 | 28.45% | <0.01 |
50–89 | 65 | 8.78% | 119 | 10.02% | |
90 or more | 84 | 11.35% | 731 | 61.53% | |
Proportion of discharge prescriptions that are oxycodone | 126 | 17.03% | 1148 | 96.55% | <0.01 |
Days of opioid prescription (mean, standard deviation) | 5.48, 2.05 | 2.23, 1.95 | <0.01 | ||